Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall

被引:297
作者
Rus, HG [1 ]
Vlaicu, R [1 ]
Niculescu, F [1 ]
机构
[1] UNIV MARYLAND,SCH MED,DEPT PATHOL,BALTIMORE,MD 21201
关键词
IL-6; IL-8; complement activation; C5b-9; atherogenesis;
D O I
10.1016/S0021-9150(96)05968-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin 6 (IL-6) and interleukin 8 (IL-8) are present in the human arterial atherosclerotic wall as cellular and extracellular deposits in the connective tissue matrix. Quantitative determinations of IL-6 by ELISA showed mean values of 27.6 +/- 3.3 ng/100 mg protein in normal intima, 37.3 +/- 2.1 ng/100 mg protein in fibrous plaque and 25.7 +/- 4.3 ng/100 mg total extracted protein in media. IL-8 levels were 3.5 +/- 0.6 ng/100 mg protein in normal intima, 11.3 +/- 2.1 ng/100 mg protein in fibrous plaque and 8.5 +/- 1.4 ng/100 mg total extracted protein in media. Fibrous plaques presented statistically significant higher levels of both IL-6 and IL-8. IL-6 and IL-8 gene transcripts were present in human iliac fibrous plaque and media prelevated at surgery indicating that a local production by the cells of the arterial wall participate to their accumulation. We also tested the role of complement activation in induction of IL-6 and IL-8 protein synthesis as well as the subsequent activation of endothelial cells. Only IL-8 was induced by complement activation and this may contribute to increased IL-8 levels found in the atherosclerotic wall. When exposed to terminal complement complexes, endothelial cells in culture also showed an increase of both DNA-synthesis and p70 S6 kinase activity indicating that complement is able to induce not only IL-8 synthesis but also cell activation. The presence of IL-6 and IL-8 in the arterial wall where complement activation also occurred, clearly show the involvement of inflammatory events in initiation and progression of atherosclerosis.
引用
收藏
页码:263 / 271
页数:9
相关论文
共 39 条
[1]  
Aarden L, 1991, Eur Cytokine Netw, V2, P115
[2]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[3]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[4]  
BARATH P, 1990, AM J PATHOL, V137, P503
[5]  
BROWN Z, 1994, AM J PATHOL, V145, P913
[6]  
CLINTON SK, 1992, ARCH PATHOL LAB MED, V116, P1292
[7]   Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts [J].
Edelmann, HML ;
Kuhne, C ;
Petritsch, C ;
Ballou, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :963-971
[8]  
EMBER JA, 1994, AM J PATHOL, V144, P393
[9]  
EVANS SW, 1987, J BIOL CHEM, V262, P4624
[10]   ENDOTHELIAL INTERLEUKIN-8 - A NOVEL INHIBITOR OF LEUKOCYTE-ENDOTHELIAL INTERACTIONS [J].
GIMBRONE, MA ;
OBIN, MS ;
BROCK, AF ;
LUIS, EA ;
HASS, PE ;
HEBERT, CA ;
YIP, YK ;
LEUNG, DW ;
LOWE, DG ;
KOHR, WJ ;
DARBONNE, WC ;
BECHTOL, KB ;
BAKER, JB .
SCIENCE, 1989, 246 (4937) :1601-1603